[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global AV Market Size to Reach USD 14,226.3 Mln by 2023, States DelveInsight in Its In-demand Report Available at MarketPublishers.com

03 Apr 2017 • by Natalie Aster

LONDON – Acne vulgaris (AV) is a disease of pilosebaceous follicles, characterised by blockage and/or inflammation of pilosebaceous units. Acne develops in regions with a high density of sebaceous glands, and is observed to affect mostly adolescents.

There were 113,959,366 diagnosed cases of AV in 7 leading markets in 2013, and the number is anticipated to amount to 136,929,289 by 2023. 

Globally, the size of the AV market was estimated at USD 5,360.1 million as of 2013, and it is projected to be worth USD 14,226.3 million by end-2023. 

In-demand research study “Acne Vulgaris (AV) - Market Insights, Epidemiology and Market Forecast-2023” elaborated by DelveInsight is devoted to an in-depth assessment of the market on a global level.

The research report offers an all-encompassing overview of the worldwide AV marketplace; provides detailed historical and forecast data on the market size of the marketplace worldwide, and for 7 major markets such as the USA, Germany, France, Spain, Italy, the UK, and Japan; provides unbiased data on total market share distribution for 7 MM in 2015 and 2023. The study also includes global historic and forecast epidemiological figures for the diagnosed cases of AV. The research report gives a comprehensive overview of the disease including physiopathology, diagnosis, signs and symptoms, management of the disease, and present-day treatment modalities. It contains all-round information on the top marketed drugs for AV, contains clinical pipeline information covering ongoing trials, clinical trials by phase, etc. The research study sheds light on the market drivers and restraints.

Market dare provided from 2013 till 2023-end.

More comprehensive reports by this publisher are available at the DelveInsight page


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]

Analytics & News

Weekly Digest